October 1998
last year’s acquisitions of speciality chemicals businesses, and is part of ICI’s move forward as a speciality company. Contact: ICI Group Headquarters, 9 Millbank, London SWIP 3JF, UK; tel: +44-l 71834 4444: fax: +44-l 71 834 2042
Cytec doubles capacity for BZT stabilizers Production capacity for benzotriazole (BZT) light stabilizers has been doubled by Cytec Industries BV, at its plant at Botlek, The Netherlands. The company markets under the name Cyasorb, and is a subsidiary of Cytec Industries Inc, which manufactures at Willow Island, W Virginia, USA. The additional capacity amounts to 1000 tonnes/year. Cytec President and Chief Operating Officer David Lilley said that the expansion will increase the ability of the company to supply customers globally, following a phase when demand exceeded available supply. Contact: Cytec Industries Inc, 5 Garret Mountain Plaza, West Paterson, NJ 07424, USA; tel: +l-201 357 3100
Slower growth at Clariant casts gloom over additives sector
Additives for Polymers
latest report showed a slowdown in growth of profits, with operating income rising 19% in the first half of 1998, to SFr565 million, on sales of SFr5.01 billion. This compared, however, with a 53% growth in operating profits in the first half of 1997. The crisis in Asia reduced sales by some SFr 100 million during the period and also affected some US markets, particularly in electronics chemicals. There was a 2% decline in prices across the whole portfolio. Stock market analysts saw the results as indicating that speciality chemicals were not immune to the downturn seen in the petrochemicals industry, as a result of overcapacity and declining markets. Now tell us something we don’t know. Contact: Clariant, Ave de Bciie, BP 149, F68331, Huningue, h’rance; tel: ~33-3 8989 6000; fax: +33-3 8989 6290
Milliken wins key patent on PP clarifying agents Milliken Chemical has won an important patent action, with the granting of a new patent in Japan covering some aspects of its clarifying agent technology. The significance is that the decision went against the formal opposition of New Japan Chemical Co, with which Milliken is involved in a broad legal dispute over the legality of its whole ‘third generation’ clarifying agent technology.
A slowdown in sales and profitability during the second quarter of the year, announced by Clariant, was seen to cast some gloom over the whole additives sector - but due more to the unrealistic expectations of analysts and investors. Chief Financial Officer Roland Lesser said the company still expected double-digit growth in net income in 1998 and predicted a “solid improvement” in income this year as a result of cost-cutting, and confirmed Clariant’s expectation that it will meet its 1999 target of 15% return on sales in all divisions.
The Japanese patent granted to the company, ‘Sorbitol agents and compositions covering same’ covers chemicals, compositions and uses of improved sorbitol acetal-based clarifjring agents, specifically agents which impart high clarity and outstanding taste and odour transfer properties to polypropylene. New Japan Chemical argued that the invention lacked inventive step.
The group announced in August that sales in local currency values had risen only 1% during the second quarter of the year, compared with 9% in the first quarter and more than 10% in the same period of last year. The
Milliken is the world leader in clarifying agents for polypropylene, marketing under the name Millad. The agents are effective through a number of processes, including injection moulding, injection/stretch blow
0 1998 Elsevier Science
7